
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Consultations

Consultations
Open consultations
Public Consultation on the revision of EU Commission guidelines on Good manufacturing Practice Medicinal Products
The European Commission launched the public consultation of the following revised guidelines on good manufacturing practices:
Chapter 3: Premises and Equipment, Chapter 5: Production, Chapter 6: Quality Control, Chapter 8: Complaints, Quality Defects and Product Recalls.
Under : Medicinal products for human use
Closed consultations
Public consultation on draft guidelines on the principles of good distribution practices for active substances for medicinal products for human use
Stakeholders are invited to comment on this draft by 30 April 2013 at the latest. Responses should be sent preferably by e-mail to sanco-pharmaceuticals-d6@ec.europa.eu, or by post to Unit SANCO/D/6, DM24 02/050, BE-1049 Brussels.
Under : Medicinal products for human use
Public consultation on draft guidelines on the formalised risk assessment for ascertaining the appropriate good manufacturing practice for excipients of medicinal products for human use
Stakeholders are invited to comment on this draft by 30 April 2013 at the latest. Responses should be sent preferably by e-mail to sanco-pharmaceuticals-d6@ec.europa.eu, or by post to Unit SANCO/D/6, DM24 02/050, BE-1049 Brussels.
Under : Medicinal products for human use
Public consultation on draft template for the qualified person’s declaration concerning GMP compliance of investigational medicinal products manufactured in non-EU countries
Stakeholders are invited to comment on this draft by 2 April 2013 at the latest. Responses should be sent preferably by e-mail to sanco-pharmaceuticals-d6@ec.europa.eu, or by post to Unit SANCO/D/6, DM24 02/050, BE-1049 Brussels.
Under : Medicinal products for human use
Public consultation on advanced therapy medicinal products
Stakeholders are invited to provide their views on the application of the Advanced Therapy Regulation at SANCO-ADVANCEDTHERAPY-REPORT@ec.europa.eu.
More information here
Under : Medicinal products for human use
Public consultation on post-authorisation efficacy studies
Under : Medicinal products for human use
Public consultation on the implementation of European Reference Networks (ERN) under the framework of Directive 2011/24/EU on the application of patients' rights in cross-border healthcare
Under : Rare diseases : Cross-border care
Public consultation on phasing-in requirements on a black symbol identifying medicinal products subject to additional monitoring
Under : Medicinal products for human use
Public Consultation on the Discussion paper addressing the New Challenges for Risk Assessment
Under : Scientific Committees
Public consultation on the implementing act on a common logo for legally-operating online pharmacies/retailers offering medicinal products for human use for sale at a distance to the public
Concept paper for public consultation on the implementing act on a common logo for legally-operating online pharmacies/retailers offering medicinal products for human use for sale at a distance to the public.
Under : Medicinal products for human use
Call for Experts to provide advice on effective ways of investing in health
Under : Healthcare
Public consultation on the delegated act on the criteria to be considered and the verifications to be made when assessing the potential falsified character of medicinal products
Under : Medicinal products for human use
Call for experts on the safety assessment of nanomaterials in cosmetic products
Under : Scientific Committees
Call for experts on the environmental risks and indirect health effects of mercury in dental amalgam
Under : Scientific Committees
Call for information on the environmental risks and indirect health effects of mercury in dental amalgam
Under : Scientific Committees
Call for experts on medical devices containing nanomaterials
Under : Scientific Committees
Call for experts on the use of dental amalgam and its substitutes
Under : Scientific Committees
Call for information on the safety of the use of dental amalgam and its substitutes
Under : Scientific Committees
Call for information on the safety of medical devices containing DEHP [di(2-ethylhexyl) phthalate
Under : Scientific Committees
Call for information on the safety of medical devices containing nanomaterials
Under : Scientific Committees
Call for information on the safety of metal-on-metal joint replacements with a particular focus on hip implants
Under : Scientific Committees
Call for experts on metal-on-metal hip implants
Call for expression of interest for experts in metal-on-metal hip implants
Under : Scientific Committees
Call for experts in EMF
Call for expression of interest for experts in Potential health effects of exposure to electromagnetic fields (EMF)
Under : Scientific Committees
Call for experts on medical devices containing DEHP
Call for expression of interest for experts on the safety of medical devices containing DEHP [di(2-ethylhexyl) phthalate]
Under : Scientific Committees
Public Consultation Paper on the Introduction of Fees for Pharmacovigilance to be charged by the European Medicines Agency
Under : Medicinal products for human use
Public Consultation Paper on the review of the Guideline on the details of the various categories of variations to the terms of marketing authorisations for medicinal products
Under : Medicinal Products for Veterinary Use : Medicinal products for human use
Public consultation on the modalities of stakeholder consultation in the voluntary Health Technology Assessment network to be established under Directive 2011/24/EU
Under : Health technology assessment
Draft template for the written confirmation for active substances imported into the European Union for medicinal products for human use
Public consultation
Under : Medicinal products for human use
Call for information on nanosilver: safety, health and environmental effects and role in antimicrobial resistance
Under : Scientific Committees
Invitation to provide input to the Chronic Disease reflection process
Additional information: Questionnaire addressed to stakeholders
Under : Major and chronic diseases
Call for information on safety of bisphenol A in medical devices
Under : Scientific Committees
Call for Information on the safety of oxidative hair dye substances and hydrogen peroxide in products to colour eyelashes
Under : Scientific Committees
Delegated act on the principles and guidelines of good manufacturing practice for active substances in medicinal products for human use - concept paper submitted for public consultation
Directive 2011/62/EU places an obligation on Member States to take appropriate measures to ensure that manufacturers of active substances on their territory comply with good manufacturing practice ('GMP') for active substances. It also places an obligation on the Commission to adopt, by means of delegated acts, the principles and guidelines of good manufacturing practice for active substances. This concept paper is being released for public consultation with a view to preparing the delegated act on principles and guidelines of good manufacturing practice for active substances in medicinal products for human use.
Under : Medicinal products for human use
Public consultation on the preliminary opinion concerning Improvement of Risk Assessment in View of the Needs of Risk Managers
Under : Scientific Committees
Public consultation on the SCCS preliminary opinion on fragrance allergens in cosmetic products
Under : Scientific Committees
Public consultation on the preliminary opinion on Nitrosamines and Secondary Amines in Cosmetic Products
Under : Scientific Committees
Public consultation on the request for a scientific opinion on the potential health effects of exposure to electromagnetic fields (EMF) and call for information
Under : Scientific Committees
Implementing act on the requirements for the assessment of the regulatory framework applicable to the manufacturing of active substances of medicinal products for human use - Concept paper submitted for public consultation
Directive 2011/62/EU introduces EU-wide rules for the importation of active substances: According to Article 46b(2) of Directive 2001/83/EC, active substances shall only be imported if, inter alia, the active substances are accompanied by a written confirmation from the competent authority of the exporting third country which, as regards the plant manufacturing the exported active substance, confirms that the standards of good manufacturing practice and control of the plant are equivalent to those in the Union. The requirement of a written confirmation is waived for third countries listed by the Commission in accordance with Article 111b of Directive 2001/83/EC. Article 111b(2) of Directive 2001/83/EC provides that the Commission adopts an implementing measure to apply these requirements. This concept paper is being rolled out for public consultation with a view to preparing this implementing act.
Under : Medicinal products for human use
Call for information on the health effects of security scanners for passenger screening (based on X-ray technology)
Under : Scientific Committees
Delegated act on the detailed rules for a unique identifier for medicinal products for human use, and its verification - Concept paper submitted for public consultation
Directive 2011/62/EU introduces obligatory 'safety features' to allow, inter alia, verification of the authenticity of medicinal products for human use ('unique identifier'). The Directive places the Commission under an obligation to adopt delegated acts setting out the details relating to inter alia the unique identifier. This concept paper is being rolled out for public consultation with a view to preparing both the impact assessment and the delegated act.
Under : Medicinal products for human use
Public consultation on measures for improving the recognition of prescriptions issued in another Member State
Under : Cross-border care
Call for experts 2011: Join the Advisory Structure of Scientific Committees and database of experts
The European Commission invites scientists to join its Advisory Structure of Scientific Committees and Database of Experts. The deadline for applications is 15 November 2011
Under
Public consultation on the preliminary opinion concerning the Health Effects of Artificial Light
Under : Scientific Committees
Public consultation on the preliminary opinion concerning Toxicity and Assessment of Chemical Mixtures
Under : Scientific Committees
Public consultation on a concept paper on an amendment of Commission Regulation (EC) No 658/2007 concerning financial penalties committed by marketing authorisation holders
The European Commission is planning to put forward, a limited and targeted amendment to Commission Regulation (EC) No 658/2007 concerning financial penalties for certain obligations in connection with centrally authorised medicinal products in the human and in the veterinary sector.
The purpose of this amendment is two-fold. Firstly, to fulfil the mandate given by the legislator in the Paediatric Regulation (EC) No 1901/2006 and secondly, to adapt Commission Regulation (EC) No 658/2007 to the modifications introduced by the new pharmacovigilance legislation in the human sector.
Under : Medicinal products for human use
Stakeholder consultation on health security in the European Union
Under : Preparedness and response
Public consultation on technical aspects of the revision of the In Vitro Diagnostic medical device Directive
Public consultation outcome
Under : Medical devices
Public consultation on a concept paper on the revision of the 'Clinical Trials Directive' 2001/20/EC
The European Commission is planning to put forward, in 2012, a legislative proposal to revise the Clinical Trials Directive 2001/20/EC.
Under : Medicinal products for human use
Public consultation on the SCCS pre-consultation opinion on the potential health risks posed by Chemical consumer products resembling food and/or having child-appealing properties
Under : Scientific Committees
Public Consultation on the pilot European Innovation Partnership on Active and Healthy ageing
Under : Ageing
Stakeholder Consultation on the Transatlantic Task Force on antimicrobial resistance
Under : Antimicrobial resistance
Public consultation on the Conclusions of the Fifth Report on Economic, Social and Territorial Cohesion
Under : Health and structural funds
Meeting with stakeholders on the study "Assessing the Impacts of Revising the Tobacco Products Directive" prepared by RAND Europe
Under : Tobacco
Public consultation on the possible revision of the Tobacco Products Directive 2001/37/EC
Under : Tobacco
Qualification of hygienic tampons containing lactic acid producing baceria
Public Consultation outcome
Under : Medical devices
Call for experts in ophthalmology
Call for expression of interest for experts in ophthalmology in relation to the work on health effects of artificial light.
Under : Scientific Committees : Dialogue and collaboration
Public consultation on the SCENIHR pre-consultation opinion on the Scientific Basis for a Definition of the Term "Nanomaterial"
Under : Scientific Committees : Dialogue and collaboration
Public consultation on the SCENIHR pre-consultation opinion on the Addictiveness and Attractiveness of Tobacco Additives
Under : Scientific Committees : Dialogue and collaboration
Call for information on the toxicity and the assessment of mixtures of chemicals
Under : Scientific Committees : Dialogue and collaboration
Public consultation on the preliminary opinion concerning the critical review of any new evidence on the hazard profile, health effects, and human exposure to fluoride and the fluoridating agents of drinking water
Under : Scientific Committees
Stakeholder Consultation on Strengthening European Union Preparedness on Pandemic Influenza
Under : Preparedness and response
Call for Information on Health Effects of Artificial Light
Under : Scientific Committees : Dialogue and collaboration
Public consultation on the legal framework for veterinary medicinal products: "Better regulation of veterinary pharmaceuticals: how to put in place a simpler legal framework, safeguarding public and animal health while increasing the competitiveness of companies"
By means of this public consultation DG SANCO intends to consult all stakeholders. The paper provides a basis for discussion on key issues and key items where a need and/or possible amendments of the legal framework have already been identified by stakeholders. The purpose of the paper is not to outline detailed legal amendments.
Under : Pharmaceuticals
Public consultation on the SCCS preliminary opinion on the antimicrobial resistance effect of triclosan
Under : Scientific Committees : Dialogue and collaboration
Call for experts in behavioural psychology
Call for expression of interest for experts in behavioural psychology in relation to the work on potential health risks posed by food-imitating and child-appealing chemical consumer products
Under : Scientific Committees : Dialogue and collaboration
Public consultation on environmental and health effects posed by depleted uranium
Under : Scientific Committees : Dialogue and collaboration
Public Consultation - Towards a Strategic Nanotechnology Action Plan (SNAP) 2010-2015
Under : Nanotechnology
Public consultation on a working mandate for a scientific opinion on health effects of artificial light
Under : Dialogue and collaboration : Scientific Committees
Call for Information on the addictiveness and attractiveness of tobacco additives
Under : Dialogue and collaboration : Tobacco : Scientific Committees
Call for Information on the safety of reprocessed single-use medical devices
Under : Dialogue and collaboration : Scientific Committees
Call for the submission of data or other information on potential health risks posed by food-imitating and child-appealing chemical consumer products
Under : Dialogue and collaboration : Scientific Committees
2nd public call for the submission of new information or data on the hazard profile, health effects, and human exposure to fluoride and information and data on the health risks that may be associated with the use of most common drinking water fluoridation agents like silicofluorides (e.g. (hydro)fluorosilicic acid, sodium silicofluoride).
Under : Dialogue and collaboration : Scientific Committees
Call for information on Mercury Sphygmomanometers in Healthcare and the Feasibility of Alternatives
Under : Dialogue and collaboration : Scientific Committees
Scientific Hearing on Nanotechnology - Launch of Public Consultation
Under : Scientific Committees : Nanotechnology : Dialogue and collaboration
Public Consultation on the Risk Assessment Advanced Training Programme (RAAP) Guidelines
Under : Scientific Committees : Dialogue and collaboration
Call for information on the hazard profile, health effects, and human exposure to fluoride and information and data on the health risks that may be associated with the use of most common drinking water fluoridation agents like silicofluorides (e.g. (hydro)fluorosilicic acid, sodium silicofluoride).
Under : Dialogue and collaboration : Scientific Committees
Consultation: EU action to reduce health inequalities
Under : Social determinants and health inequalities
Public consultation on the Green Paper on the European Workforce for Health
Under : Health workforce
Public Consultation on SCHER 'working mandate': The hazard profile, health effects, and human exposure to fluoride and information and data on the health risks that may be associated with the use of most common drinking water fluoridation agents like silicofluorides (e.g. (hydro)fluorosilicic acid, sodium silicofluoride)
Under : Dialogue and collaboration : Scientific Committees
Public consultation on the SCCP/SCHER/SCENIHR preliminary report on the "Use of the Threshold of Toxicological Concern (TTC) Approach for the Safety Assessment of Chemical Substances"
Under : Scientific Committees : Dialogue and collaboration
Public Consultation on the SCHER preliminary report on Risk assessment methodologies and approaches for mutagenic and carcinogenic substances
Under : Scientific Committees : Dialogue and collaboration
Public Consultation on the SCENIHR preliminary report on Effects of the Active Substances in Biocidal Products on Antibiotic Resistance
Under : Dialogue and collaboration : Scientific Committees : Antimicrobial resistance
Public Consultation on the SCENIHR preliminary report on Potential health risks of exposure to noise from personal music players and mobile phones including a music playing function
Under : Scientific Committees : Population groups : Dialogue and collaboration
Call for information on the need for non-human primates in biomedical research, production and testing of products and devices
Under : Dialogue and collaboration : Scientific Committees
Public Consultation on SCHER 'Working mandate': The need for non-human primates in biomedical research, production and testing of products and devices
Under : Dialogue and collaboration : Scientific Committees
Call for information on assessment of the Antibiotic Resistance Effects of Biocides
Under : Dialogue and collaboration : Scientific Committees : Antimicrobial resistance
Call for information on phthalates in school supplies
Under : Dialogue and collaboration : Scientific Committees
Call for information on the use of the Treshold of Toxicological Concern (TTC) approach for the safety assessment of chemicals
Under : Dialogue and collaboration : Scientific Committees
Call for information on risk Assessment methodologies and approaches for mutagenic and carcinogenic substances
Under : Dialogue and collaboration : Scientific Committees
Public Consultation on 'Working mandate': Phthalates in school supplies
Under : Dialogue and collaboration : Scientific Committees
Call for information on potential health risks of exposure to noise from personal music players and mobile phones including a music playing function
Under : Dialogue and collaboration : Scientific Committees
Public consultation on the SCENIHR preliminary report on "The safety of dental amalgam and alternative dental restoration materials for patients and users"
Under : Scientific Committees : Dialogue and collaboration
Public consultation on the SCHER preliminary report on "The environmental risks and indirect health effects of mercury in dental amalgam"
Under : Scientific Committees : Dialogue and collaboration
Public Consultation on 'Working mandate': the use of the Treshold of Toxicological Concern (TTC) approach for the safety assessment of chemicals
Under : Dialogue and collaboration : Scientific Committees
Public Consultation regarding a European Action in the Field of Rare Diseases
Under : Rare diseases
Public Consultation on 'Working mandate': Risk Assessment methodologies and approaches for mutagenic and carcinogenic substances
Under : Dialogue and collaboration : Scientific Committees
Public consultation on the SCENIHR preliminary report on "Safety of medical devices containing DEHP-plasticized PVC or other plasticizers on neonates and other groups possibly at risk"
Under : Scientific Committees : Dialogue and collaboration
Public consultation on the SCENIHR preliminary report on "Health Effects of Smokeless Tobacco Products"
Under : Dialogue and collaboration : Tobacco : Scientific Committees
Public consultation on Green Paper on Bio-preparedness
Under : Preparedness and response
Public consultation on the SCCP preliminary report on "Safety of Nanomaterials in Cosmetic Products"
Under : Scientific Committees : Nanotechnology : Dialogue and collaboration
Public consultation on the SCCP preliminary report on "Sensitivity to Hair Dyes - Consumer Self Testing"
Under : Scientific Committees : Dialogue and collaboration
Call for information on environmental risks and indirect health effects of mercury in dental amalgam
Under : Dialogue and collaboration : Scientific Committees
Call for information on the safety of dental amalgam and alternative dental restoration materials for patients and users
Under : Dialogue and collaboration : Scientific Committees
Call for the submission of safety data made available after 15 March 2005 on the use of hydrogen peroxide, in its free form or when released, in oral hygiene products
Under : Dialogue and collaboration : Scientific Committees
Public consultation SCENIHR Opinion on the appropriateness of the risk assessment methodology in accordance with the Technical Guidance Documents for new and existing substances for assessing the risks of nanomaterials
Under : Dialogue and collaboration : Scientific Committees
Consultation on the Green Paper "Towards a Europe free from tobacco smoke: policy options at EU level"
Under : Tobacco
High Level Pharmaceutical Forum Public consultation on Health-related information to patients
Under : Pharmaceuticals
Public consultation on the SCHER preliminary report on Risk assessment on indoor air quality
Under : Scientific Committees : Healthy environments : Dialogue and collaboration
Consultation regarding Community action on health services
Under : Healthcare : Health workforce : Cross-border care
Call for information on Health Safety of Nanomaterials in Cosmetic Products
Under : Dialogue and collaboration : Scientific Committees : Nanotechnology
Public consultation on the SCENIHR Opinion on Possible effects of Electromagnetic Fields (EMF) on Human Health
Under : Scientific Committees : Healthy environments : Electromagnetic fields : Dialogue and collaboration
Call for information on Health Effects of Smokeless Tobacco Products
Under : Dialogue and collaboration : Tobacco : Scientific Committees
Call for information on the safety of medical devices containing DEHP-plasticized PVC or other plasticizers on neonates and other groups possibly at risk
Under : Dialogue and collaboration : Scientific Committees
European Commission Green paper 'Promoting the Mental Health of the Population. Towards a Strategy on Mental health for the European Union'
Under : Mental health
Public consultation: SCCP Opinion on biological effects of ultraviolet radiation relevant to health with particular reference to sun beds for cosmetic purposes
Under : Dialogue and collaboration : Scientific Committees
European Commission Green paper "Promoting healthy diets and physical activity: a European dimension for the prevention of overweight, obesity and chronic diseases"
Under : Nutrition and physical activity
Public consultation: SCENIHR Opinion on The Safety of Human-derived Products with regard to Variant Creutzfeldt-Jakob Disease (vCJD)
Under : Dialogue and collaboration : Scientific Committees : Communicable diseases
Open consultation on improving patient safety by prevention and control of healthcare-associated infections
Under : Patient safety
Public consultation SCENIHR Opinion on How to Assess the Potential Risks of Nanotechnologies
Under : Dialogue and collaboration : Scientific Committees : Nanotechnology
Open Consultation on Draft Technical Requirements for Tissues and cells
Under : Blood, tissues and organs
Public consultation on a preliminary opinion on hydrogen peroxide in tooth whitening products
Under : Dialogue and collaboration : Scientific Committees
Open Consultation on 'Technical requirements for the donation procurement and testing of human tissues and cells'
Under : Blood, tissues and organs
Consultation on the WHO Framework Convention on tobacco control
Under : Tobacco